Roberta Rolla

Summary

Country: Italy

Publications

  1. ncbi request reprint Side effects associated with ultrarapid cytochrome P450 2D6 genotype among women with early stage breast cancer treated with tamoxifen
    R Rolla
    Departmentt of Medical Sciences, University Amedeo Avogadro of East Piedmont, Novara, Italy
    Clin Lab 58:1211-8. 2012
  2. ncbi request reprint Estimating the cost of redundancy in molecular diagnostics: the case of activated protein C resistance and factor V Leiden
    Roberta Rolla
    Dept of Medical Sciences, University Amedeo Avogadro of East Piedmont, Novara, Italy
    Clin Lab 57:711-7. 2011
  3. doi request reprint Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy
    Monica Verdoia
    Division of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy
    Atherosclerosis 243:389-94. 2015
  4. doi request reprint Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy
    Monica Verdoia
    Department of Cardiology, Ospedale Maggiore della Carita, Eastern Piedmont University, C so Mazzini, 18, 28100, Novara, Italy
    Cardiovasc Drugs Ther 29:443-50. 2015
  5. doi request reprint Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes
    Monica Verdoia
    Division of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy
    J Thromb Thrombolysis 41:663-70. 2016
  6. doi request reprint Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation
    Monica Verdoia
    Division of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy
    Vascul Pharmacol 77:48-53. 2016
  7. doi request reprint Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor
    Lucia Barbieri
    Department of Cardiology, Ospedale Maggiore della Carita, Eastern Piedmont University, Novara, Italy
    Vascul Pharmacol 79:11-5. 2016
  8. doi request reprint Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor
    Matteo Nardin
    Division of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy Clinical Chemistry, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy and Department of Cardiology, UMC St Radboud, Nijmegen, The Netherlands
    J Cardiovasc Pharmacol 66:364-70. 2015
  9. doi request reprint Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid
    Monica Verdoia
    Department of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy Department of Clinical Chemistry, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy Department of Translational Medicine, Centro di Biotecnologie per la Ricerca Medica Applicata BRMA, Eastern Piedmont University, Novara, Italy and Department of Cardiology, UMC St Radboud, Nijmegen, The Netherlands
    J Cardiovasc Pharmacol 66:35-40. 2015
  10. doi request reprint Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions
    Alessandro Lupi
    Hospital Cardiology, Maggiore della Carita Hospital, Novara, Italy
    EuroIntervention 11:1380-8. 2016

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Side effects associated with ultrarapid cytochrome P450 2D6 genotype among women with early stage breast cancer treated with tamoxifen
    R Rolla
    Departmentt of Medical Sciences, University Amedeo Avogadro of East Piedmont, Novara, Italy
    Clin Lab 58:1211-8. 2012
    ..The aim of this study was therefore to evaluate the association between the presence of multiple functional CYP2D6 alleles and the occurrence of side effects...
  2. ncbi request reprint Estimating the cost of redundancy in molecular diagnostics: the case of activated protein C resistance and factor V Leiden
    Roberta Rolla
    Dept of Medical Sciences, University Amedeo Avogadro of East Piedmont, Novara, Italy
    Clin Lab 57:711-7. 2011
    ..A survey, including 4969 requests, was performed on the activity of a typical Molecular Diagnostics Laboratory in order to estimate the costs due to reagents, instrumentation and personnel...
  3. doi request reprint Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy
    Monica Verdoia
    Division of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy
    Atherosclerosis 243:389-94. 2015
    ..Therefore, the aim of the current study was to investigate any impact of rosuvastatin or atorvastatin co-administration on platelet reactivity in patients receiving dual antiplatelet therapy (DAPT)...
  4. doi request reprint Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy
    Monica Verdoia
    Department of Cardiology, Ospedale Maggiore della Carita, Eastern Piedmont University, C so Mazzini, 18, 28100, Novara, Italy
    Cardiovasc Drugs Ther 29:443-50. 2015
    ....
  5. doi request reprint Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes
    Monica Verdoia
    Division of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy
    J Thromb Thrombolysis 41:663-70. 2016
    ..In patients treated with ticagrelor, the levels of circulating reticulated platelets assessed at 30-90 days post-ACS are not associated with platelet reactivity or the occurrence of HRPR. ..
  6. doi request reprint Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation
    Monica Verdoia
    Division of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy
    Vascul Pharmacol 77:48-53. 2016
    ..However, so far, few data have investigated the prevalence and predictors of HRPR in unselected patients treated with ticagrelor, that is therefore the aim of the current study...
  7. doi request reprint Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor
    Lucia Barbieri
    Department of Cardiology, Ospedale Maggiore della Carita, Eastern Piedmont University, Novara, Italy
    Vascul Pharmacol 79:11-5. 2016
    ..Therefore, the aim of our study was to evaluate the impact of CKD on platelet function in patients treated with DAPT after a recent acute coronary syndrome (ACS) or PCI...
  8. doi request reprint Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor
    Matteo Nardin
    Division of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy Clinical Chemistry, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy and Department of Cardiology, UMC St Radboud, Nijmegen, The Netherlands
    J Cardiovasc Pharmacol 66:364-70. 2015
    ..Aim of this study was to investigate the impact of body mass index (BMI) on platelet reactivity in patients on DAPT...
  9. doi request reprint Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid
    Monica Verdoia
    Department of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy Department of Clinical Chemistry, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy Department of Translational Medicine, Centro di Biotecnologie per la Ricerca Medica Applicata BRMA, Eastern Piedmont University, Novara, Italy and Department of Cardiology, UMC St Radboud, Nijmegen, The Netherlands
    J Cardiovasc Pharmacol 66:35-40. 2015
    ..We therefore aimed to evaluate the effects of homocysteine (Hcy) levels on platelet reactivity in patients receiving acetylsalicylic acid (ASA) with or without ADP antagonists...
  10. doi request reprint Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions
    Alessandro Lupi
    Hospital Cardiology, Maggiore della Carita Hospital, Novara, Italy
    EuroIntervention 11:1380-8. 2016
    ..To evaluate the prognostic implications of baseline cardiac troponin (cTn) values in the normal range in stable coronary artery disease (CAD) patients successfully treated with percutaneous coronary intervention (PCI)...
  11. doi request reprint Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients
    Roberta Rolla
    Clinical Chemistry Laboratory, Department of Health Sciences, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
    J Nephrol 28:749-55. 2015
    ....
  12. doi request reprint PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty
    Monica Verdoia
    Division of Cardiology, Azienda Ospedaliera Universitaria Maggiore Della Carità, Eastern Piedmont University, Novara, Italy
    Blood Coagul Fibrinolysis 24:411-8. 2013
    ..This study showed that Leu33Pro polymorphism of Gp IIIa does not affect the extent of inhibition of platelet aggregation by Gp IIb-IIIa inhibitors...
  13. ncbi request reprint Hemolysis is a major cause of variability in insulin measurement during oral glucose tolerance test in children
    Giorgio Bellomo
    Dept of Medical Sciences, University Amedeo Avogadro of East Piedmont, Novara, Italy
    Clin Lab 58:67-74. 2012
    ..The present study was performed to characterize the effects of hemolysis on insulin assays, in order to assess the need to generate automatic hemolysis reports and/or to reject hemolyzed samples...
  14. doi request reprint Plasma fibrinogen levels and restenosis after primary percutaneous coronary intervention
    Alessandro Lupi
    Cardiologia Ospedaliera, Ospedale Maggiore della Carita, Corso Mazzini 18, Novara, Italy
    J Thromb Thrombolysis 33:308-17. 2012
    ..Our study suggests that increased plasma fibrinogen levels are related to ISR in STEMI patients undergoing primary PCI. Larger studies are warranted to assess the prognostic value of fibrinogen over harder end-points...
  15. pmc Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C
    Massimo Sartori
    Gastroenterology Units, Ospedale Maggiore della Carita, Novara, Italy
    Gut 56:693-8. 2007
    ..Iron accumulation is a well-known risk factor for the progression of chronic hepatitis C (CHC) to fibrosis. However, the profibrogenic role of the genes controlling iron homeostasis is still controversial...